n polypeptide hormone secreted by the mucous lining of the stomach; when peptides and amino acids are present in the small intestine the secretion of gastric acid is stimulated
Cancer Advances Announces Allowance of a New Patent to Its Suite of Gastrin Inhibitor Products Cancer Advances, Inc. (Cancer Advances), a wholly owned, biotechnology portfolio company of Cato BioVentures, announces the allowance of a new patent. The newly released patent covers monoclonal antibodies to the gastrin hormone and has been allowed in Canada. (PRWeb July 15, 2013) Read the full story at http://www.prweb.com/releases/2013/7/prweb10921168.htm
July 15, 2013 - PRWeb